Table 5. Adverse Events during the Trial.
Characteristic | Placebo | Pentoxifylline | P-value1 |
Symptoms | |||
Total | 21 | 14 | 0.73 |
Gastrointestinal | 8 | 7 | |
Rash | 2 | 1 | |
Flushing | 2 | 0 | |
Headache | 1 | 2 | |
Cough | 2 | 0 | |
Other | 6 | 4 | |
Laboratory Abnormalities | |||
Total | 2 | 6 | 0.86 |
Neutropenia | 0 | 2 | |
Hypokalemia | 0 | 1 | |
Hyperkalemia | 1 | 0 | |
Elevated liver function tests | 1 | 1 | |
Hyperglycemia | 0 | 1 | |
Dipstick proteinuria | 0 | 1 |
Notes: Data are cumulative number of adverse events.
For comparisons between placebo and pentoxifylline groups.